Pharma Industry Insights & Resources

Pfizer CentreOne appoints new General Manager Andrew Moore

Pfizer CentreOne, a global pharmaceutical contract development and manufacturing organization (CDMO) embedded within Pfizer and a leading supplier of specialty APIs, today announced the appointment of Andrew Moore as general manager.

Oral Solid Dose Regulatory Hurdles and How to Approach Them

In your quest to meet the regulatory requirements for your oral solids project you may encounter significant hurdles. Anticipating these early on and thoroughly planning your approach can help.

Webinar | Key Trends in Contract Manufacturing

Growing demand for pharma and biotech outsourcing presents a tremendous opportunity for CDMOs, but the impact of COVID-19 adds to a growing list of considerations for finding the right commercial partners to deliver critical medicines. A recent CPhI webinar sponsored by Pfizer CentreOne she

How To Select an API Partner for Strategic Success - Pharmaceutical Online

A strategic partner should always seek ways to innovate and improve your compound or product’s value, and do it with the dedication of a partner, not a supplier. With the growing importance of contract services and plenty of providers, it is more critical than ever to make the right choice.

Technical Considerations For Developing Oral Solids - Outsourced Pharma

Navigating your oral solids project from development through commercial manufacture can be a challenging path. In a two-part series, four oral solids experts from Pfizer CentreOne’s global network and partner organizations discuss the technical considerations to be aware of.

Liposomal and Nanoparticle Technology at Pfizer Melbourne

Medical science is continuously searching for better ways to administer drugs into the body and to maximise the therapeutic effectiveness of the drugs given.

Q&A with Pfizer CentreOne's Global Customer Experience Lead Olesya Govorun - Colliers LabNotes

Joe Fetterman from Colliers International sat down with Pfizer CentreOne's Olesya Govorun to discuss her new role. As Global Customer Experience Lead, Olesya helps ensure that Pfizer CentreOne is known not only for the caliber of its capabilities but also the quality of its services.

Small Molecule APIs: Aligning Drug Strategy with Partnering Strategy

Development of novel small molecule active pharmaceutical ingredients (APIs) is increasingly turned over to outsourced partners who have become the primary drivers of the product’s overall development and go-to-market strategy.

How Oral Solid Coating Technologies Can Enhance Delivery Strategy - Pharmaceutical Online

Oral solid dose (OSD) remains a dominant form in drug delivery and development and there are continual advances to improve oral solid stability, integrity, and robustness through technology platforms, including coating technologies.

Integrated CDMO Misconceptions

Access to the expert capabilities of embedded CDMOs is offering great economies and competitive experience. However, embedded CDMOs are still surrounded by misconceptions.

Webinar | Coating: Curing Your Complex Oral Solid Dose challenges

Coating technologies have been a mainstay in oral solid dose (OSD) drug development for many decades and deployed successfully in hundreds of drug products for multiple therapeutic areas.

An Easier Pill to Swallow - Pharma Manufacturing

The increasing complexity of molecules in the drug pipeline is bringing greater challenges in formulation and scale-up. OSD manufacturers must be armed with a breadth of technology and expertise from a multidisciplinary team.